Daniel M Johnstone Selected Research

Mental Disorders (Mental Disorder)

11/2019	"Photobiomics": Can Light, Including Photobiomodulation, Alter the Microbiome?
1/2016	Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel M Johnstone Research Topics

Disease

13	Parkinson Disease (Parkinson's Disease) 01/2023 - 01/2013
5	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 01/2013
3	Gliosis 11/2016 - 01/2013
2	Inflammation (Inflammations) 12/2021 - 11/2019
2	Asthma (Bronchial Asthma) 12/2021 - 01/2020
2	Iron Overload 01/2020 - 01/2012
2	Fibrosis (Cirrhosis) 01/2020 - 01/2020
2	Mental Disorders (Mental Disorder) 11/2019 - 01/2016
2	Brain Diseases (Brain Disorder) 11/2019 - 01/2016
2	Hemochromatosis (Bronze Diabetes) 01/2016 - 01/2012
1	Hypoxia (Hypoxemia) 01/2024
1	Cerebral Hemorrhage 01/2024
1	Dementia (Dementias) 01/2024
1	Hemorrhage 01/2024
1	Infections 01/2024
1	Iron Deficiencies 12/2021
1	Neuroblastoma 07/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020
1	Respiratory Hypersensitivity 01/2020
1	Idiopathic Pulmonary Fibrosis 01/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2019
1	Stroke (Strokes) 11/2019
1	Pain (Aches) 11/2019
1	Ischemia 06/2018
1	Neurodegeneration with brain iron accumulation (NBIA) 03/2016
1	Multiple Sclerosis 01/2016
1	Cardiovascular Infections 01/2015
1	Neoplasms (Cancer) 01/2015
1	Macular Degeneration (Age-Related Maculopathy) 01/2013
1	Needlestick Injuries (Needlestick Injury) 01/2013
1	Amyloid Plaque 01/2013

Drug/Important Bio-Agent (IBA)

11	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2019 - 01/2013
6	IronIBA 12/2021 - 01/2012
4	phytobacteriomycin (PBM)IBA 01/2023 - 01/2019
2	Transferrin Receptors (Transferrin Receptor)IBA 01/2020 - 01/2020
2	NeurotoxinsIBA 10/2019 - 06/2018
1	HaptoglobinsIBA 01/2024
1	Hemoglobins (Hemoglobin)IBA 01/2024
1	HemopexinIBA 01/2024
1	Glutamic Acid (Glutamate)FDA Link 01/2024
1	Neuroprotective AgentsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 07/2020
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2020
1	Chelating AgentsIBA 01/2020
1	MetalsIBA 01/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	CytokinesIBA 01/2020
1	indium-bleomycinIBA 01/2020
1	Oxidopamine (6 Hydroxydopamine)IBA 06/2016
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Amyloid (Amyloid Fibrils)IBA 01/2013
1	AntioxidantsIBA 01/2013
1	Heme (Haem)IBA 01/2013

Therapy/Procedure

6	Low-Level Light Therapy (LLLT) 01/2023 - 03/2013
1	Injections 06/2018
1	Optical Fibers 06/2016
1	Phototherapy (Light Therapy) 01/2015
1	Therapeutics 01/2015